Databases (DBs) are required by various omics fields because the volume of molecular biology data is increasing rapidly. In this study, we provide instructions for users and describe the current status of our metabolite activity DB. To facilitate a comprehensive understanding of the interactions between the metabolites of organisms and the chemical-level contribution of metabolites to human health, we constructed a metabolite activity DB known as the KNApSAcK Metabolite Activity DB. It comprises 9,584 triplet relationships (metabolite-biological activity-target species), including 2,356 metabolites, 140 activity categories, 2,963 specific descriptions of biological activities and 778 target species. Approximately 46% of the activities described in the DB are related to chemical ecology, most of which are attributed to antimicrobial agents and plant growth regulators. The majority of the metabolites with antimicrobial activities are flavonoids and phenylpropanoids. The metabolites with plant growth regulatory effects include plant hormones. Over half of the DB contents are related to human health care and medicine. The five largest groups are toxins, anticancer agents, nervous system agents, cardiovascular agents and non-therapeutic agents, such as flavors and fragrances. The KNApSAcK Metabolite Activity DB is integrated within the KNApSAcK Family DBs to facilitate further systematized research in various omics fields, especially metabolomics, nutrigenomics and foodomics. The KNApSAcK Metabolite Activity DB could also be utilized for developing novel drugs and materials, as well as for identifying viable drug resources and other useful compounds.
Introduction
Plant metabolomics has been highlighted in studies conducted to detect complete sets of metabolites in tissues and cells (Bino et al. 2004 , Tohge and Fernie 2009 , Macel et al. 2010 , Saito and Matsuda 2010 , as well as in more complex fields, such as understanding species-species relationships based on secondary metabolites. This has led to further studies of the biological interactions between organisms in ecosystems (Ikeda et al. 2013 ) because secondary metabolites are used during plant interactions in the environment, such as pest and pathogen defense compounds, and in UV-B sunscreens (Dixon 2001 , Halkier and Gershenzon 2006 , Bednarek and Osboum 2009 . Metabolome studies have also been extended from model species such as crops and medicinal plants to health care and medicinal systems based on the interactions between organisms and humans (Ikeda et al. 2013, Kell and Goodacre 2013) . Secondary metabolites continue to play highly significant roles in the drug discovery process because the available biodiversity is an almost unlimited source of novel chemicals that are potential drug leads. The secondary metabolites synthesized by plants, fungi and microorganisms are diverse, e.g. there are at least 30,000 terpenoids (Connolly and Hill 1991) , 9,000 flavonoids, 1,600 isoflavonoids and 12,000 alkaloids (Ziegler and Facchini 2008) . These metabolites have been deposited in the species-metabolite relational database (DB) known as the KNApSAcK Core DB, which contains 109,976 speciesmetabolite relationships that encompass 22,399 species and 50,897 metabolites (Afendi et al. 2012 ). These secondary metabolites have a wide variety of activities such as UV protection, flower coloration, interspecies interaction and plant defense, which are involved in the interactions between plants and their environmental partners (Martens and Mithofer 2005, Lapcik 2007 ). Furthermore, a wide variety of secondary metabolites are exploited in human health care (Diplock 1999 , Krzyzanowska et al. 2010 , Wahle et al. 2010 .
To facilitate a comprehensive understanding of the interactions between the metabolites of organisms and their chemical-level contribution to human health, we constructed a metabolite-activity DB called the KNApSAcK Metabolite Activity DB, which comprises triplets, i.e. metabolites, target species and activities. In the present study, we introduce the KNApSAcK Metabolite Activity DB and describe the current status of the KNApSAcK Family DBs. The basis of our Metabolite Activity DB was a search of scientific publications up to September 2012 using Pubmed (http://www.ncbi.nlm.nih.gov/pubmed) and Google Scholar (http://scholar.google.co.jp/). This literature search using the keywords 'metabolite' and 'activity/function' provided 9,584 records of triplet relations (metabolite-biological activity-target species), including 2,356 metabolites, 140 activity categories, 2,963 specific descriptions of biological activities and 778 target species. The DB allows users to search for both metabolites using descriptions of biological activities and activities using the KNApSAcK compound ID, metabolite name, target species, molecular formula and CAS ID. Furthermore, the biological species that synthesize a target metabolite can be identified by connecting to the species-metabolite relational database KNApSAcK Core (Afendi et al. 2012) .
Search options in the KNApSAcK Metabolite Activity DB Fig. 1 Table 1 , individual biological activity, target species, molecular formula and CAS ID (b2 in Fig. 1B) . If users input 'Enhance stem growth' in the text box for the activity category and select the corresponding check box, and then click the List button, the results retrieved are those shown in Fig. 2A . The attributes in the list are C_ID (a1 in Fig. 2A ), metabolite name (a2 in Fig. 2A ), activity category (a3 in Fig. 2A ), biological activity (a4 in Fig. 2A ), target species (a5 in Fig. 2A ) and references (i.e. the source of the metabolite information, a6 in Fig. 2A) , from left to right. For example, in the first five lines, gibberellin A1 has 'Enhance stem growth' in the activity category and this metabolite is available from four species, Pisum sativum cv. Progress No. 9, Lactuca sativa, Oryza sativa cv. Tanginbozu and Zea mays d1 and d3 ( Fig. 2A) . Information related to any of the metabolites shown in Fig. 2A can be obtained by clicking the C_ID. Fig. 2B shows the search results obtained by clicking the C_ID, C00000003 (Fig. 2B) , which were retrieved from the KNApSAcK Core (Afendi et al. 2012) .
Statistical Analysis of the Biological Activity DB Fig. 3 represents as a pie chart the relative frequencies of the 21 metabolite activity general descriptions listed in Table 1 . The metabolite activities are tentatively classified into two types of activities, i.e. chemical ecology, which involves metabolites related to interactions between species and the natural regulation of organisms, and human health care and medicine, which concerns metabolites utilized by human health care applications. In the current version of the Metabolite Activity DB, approximately 46% of the activities correspond to chemical ecology, mainly antimicrobial agents (19.5%) and plant The 140 categories are tentatively classified into 21 general descriptions, and 6,355 records in the Metabolite Activity DB are assigned to 140 activity categories. The numbers in parentheses are the total number of activities in each general description.
growth regulators (14.9%) (Fig. 3) . Most of the metabolites with roles as antimicrobial agents are flavonoids, such as amentoflavone, daidzein, formononetin, pinosylvin and resveratrol, and phenylpropanoids, such as marmesin, eugenol and gallic acid, which are effective against 151 bacterial species and 90 fungi. The Metabolite Activity DB includes 192 metabolites with plant growth regulatory effects, including plant hormones such as auxins, gibberellins, cytokinins and ABA, which have effects on 202 plant species. Secondary metabolites also have important roles in human health care because of their medicinal effects (Diplock 1999 , Krzyzanowska et al. 2010 , Wahle et al. 2010 , and over half of the records in the Metabolite Activity DB are related to human health care and medicine (Fig. 3) . The five largest groups are toxins (10.1%), anticancer agents (7.79%), nervous system agents (6.98%), cardiovascular agents (6.26%) and nontherapeutic agents (5.22%), such as flavors and fragrances. Most of these are related to medicinal drugs, but metabolites with roles as nutrients (1.20%) are also included. The integration of the human genome and nutrition has led to the emergence of nutrigenetics and nutrigenomics (Fenech et al. 2011) . Similarly, the integration of food and health has resulted in the emergence of foodomics, because food is now considered as a nutrient and as an affordable way of preventing future disease (García-Cañas et al. 2012) . The enrichment of records in the Metabolite Activity DB plays key roles in health care and medicinal applications, such as nutrigenetics, nutrigenomics and foodomics, as well as medical genomics.
To examine relationships between chemical structure and bioactivity, we tentatively classified the metabolites into 11 structural groups according to KEGG BRITE DB (http://www. genome.jp/kegg/brite.html) and assessed the similarity of metabolites based on 140 activities shown in Table 1 . Fig. 5 shows two-dimensional clustering. Similarities between metabolites are represented in the horizontal axis, and similarities in co-occurrence of activities are represented in the vertical axis. We then provisionally classified metabolites into nine clusters (Fig. 5) whose major activities are antibacterial (E32 in Table 1 ) in cluster 1, toxic (M82) in cluster 2, antifungal (E35) in cluster 3, antihypertensive (M26) in cluster 4, fragrance and feeding attractant (M65, M66 and E17) in cluster 5, pigment (M67) in cluster 6, antitumor (M46 and M47) in cluster 7, growth enhancement of stem, leaf, fruiting, germination and flowering (E02, E07, E04, E06, E01 and E05) in cluster 8 and broad effects in cluster 9. Though most of the chemical groups in the nine clusters are characterized by flavonoids and/or alkaloids, most of the metabolites belong to glucosinolates in cluster 5, many metabolites are quinones and betalains in cluster 6, and almost all the metabolites belong to terpenoids in cluster 8. Thus, relationships between fundamental chemical structures and Table 1. activities are observed in Fig. 5 . This can be associated with the evolutionary strategies of metabolic pathways to create novel metabolites in species-species relationships via secondary metabolites in ecological systems and can be also be extended to human heath care.
Relationships between the Metabolite Activity DB and the KNApSAcK Family
At present, omics biology is experiencing an explosive increase in data, i.e. the so-called big data biology, including large-scale DNA sequencing, expression analyses, the mass spectra of metabolites and phenotype studies (Birney 2012) . One of our goals is to facilitate a comprehensive understanding of the interactions between medicinal/edible plants and human health care and medicine, as well as the interactions that occur between species via metabolites. To achieve this goal, it is necessary to develop DBs that include the relationships among these omics data, as shown in Fig. 4 . For health care and pharmacology applications, we have developed four DBs (Lunch Box, DietNavi, FoodProcessor and DietDish) related to the effects of popular Japanese foodstuffs on health. We have also developed four DBs to systematize crude drugs, i.e. WorldMap (relationships between geographic zones and the usage of edible and medicinal plants), KAMPO (prescription of crude drugs in Japan), JAMU (prescription of crude drugs in Indonesia) and Tea Pot (relationships between herbal tea and health care).
Users can search metabolites based on the molecular weights estimated from their mass spectra and according to the enzyme-catalyzed reactions of the metabolites using the KNApSAcK Core DB (Afendi et al. 2012) and Motorcycle DB (Ikeda et al. 2013) , respectively. The KNApSAcK Core DB has been utilized extensively in omics science and it has about 100 citations in the scientific literature (Ikeda et al. 2013) . Users can also search activity information with the Metabolite Activity DB. The Metabolite Activity DB and other KNApSAcK Family DBs play important roles in data-intensive or data-driven biological discovery because a large open pool of data that covers the full breadth of the life sciences is required to facilitate comprehensive research (Pennisi 2005 , Thessen and Patterson 2011 , Callebaut 2012 . Thus, the metabolome needs to be connected to multifaceted information, such as species names, the utilization of crude drugs and edible plants, health care, and the proteome, such as enzyme reactions and activities. The KNApSAcK Family DBs have been enriched by addition of the Metabolite Activity DB, and the system now provides more systematized information related to metabolites in various fields, such as 'omics' sciences, particularly metabolomics, nutrigenomics and foodomics. 
Conclusion
The KNApSAcK Metabolite Activity DB provides triplet relationships between the metabolites of organisms, their biological activity and their target species. This DB facilitates the comprehension of the relationships and interactions between metabolites of organisms and the chemical-level contribution of metabolites to human health. Apart from metabolite activities A (1) (2) (3) (4) (5) (6) (7) (8) related to chemical ecology, more than half of the biological activities listed in the Metabolite Activity DB are associated with medicine and human health. In future, the Metabolite Activity DB may therefore be utilized to develop novel drugs and to find viable resources for pharmacologically or nutritionally useful compounds.
